Rimonabant — CAS 136236-51-6

Rimonabant is a high-purity Active Pharmaceutical Ingredient (API) classified as a selective Cannabinoid CB1 Receptor Antagonist. Mediocon Inc manufactures GMP-compliant Rimonabant at its facility in Aurangabad, Maharashtra, India.

• Endocannabinoid system research
• Obesity and metabolic syndrome investigation
• CB1 receptor pharmacology studies
• Smoking cessation research applications

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support